Natasha Dubois Cauwelaert

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH‐F3+GLA‐SE

Rhea N. Coler, Malcolm S. Duthie, Kimberly A. Hofmeyer et al. · Clinical & Translational Immunology · 2015 · 157 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL‐18, and IFN‐γ

Anthony L. Desbien, Jim Reed, H. Remy Bailor et al. · European Journal of Immunology · 2014 · 78 citations · Full text

Life Sciences, Immunology, Pharmacology +17

The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction

Natasha Dubois Cauwelaert, Anthony L. Desbien, Thomas E. Hudson et al. · PLoS ONE · 2016 · 53 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses

Emilie Seydoux, Hong Liang, Natasha Dubois Cauwelaert et al. · The Journal of Immunology · 2018 · 50 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +16

IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants

Anthony L. Desbien, Natasha Dubois Cauwelaert, Jim Reed et al. · The Journal of Immunology · 2016 · 42 citations · Full text

Life Sciences, Immunology, Immunization +16